Literature DB >> 23812933

Population-based incidence of myeloid malignancies: fifteen years of epidemiological data in the province of Girona, Spain.

Gemma Osca-Gelis, Montserrat Puig-Vives, Marc Saez, David Gallardo, Natalia Lloveras, Rafael Marcos-Gragera.   

Abstract

Entities:  

Keywords:  HAEMACARE project; WHO classification; myeloid malignancies

Mesh：

Year:  2013        PMID： 23812933      PMCID： PMC3729892          DOI： 10.3324/haematol.2013.084061

Source DB:  PubMed          Journal:  Haematologica        ISSN： 0390-6078            Impact factor:   9.941


× No keyword cloud information.
  15 in total

Review 1.  Epidemiology of hematological malignancies.

Authors:  D Rodriguez-Abreu; A Bordoni; E Zucca
Journal:  Ann Oncol       Date:  2007-01       Impact factor: 32.976

2.  Significant increase in the apparent incidence of essential thrombocythemia related to new WHO diagnostic criteria: a population-based study.

Authors:  François Girodon; Gilles Bonicelli; Céline Schaeffer; Morgane Mounier; Serge Carillo; Ingrid Lafon; Paule Marie Carli; Inès Janoray; Emmanuelle Ferrant; Marc Maynadié
Journal:  Haematologica       Date:  2009-04-18       Impact factor: 9.941

3.  Hematological malignancies in the island of Sardinia, 1974-1993: age and sex distributions and temporal changes in incidence.

Authors:  G Broccia; Wilma Deplano; P Dessalvi; Barbara Giannico; G Luxi; E Chessa; Antonietta Murru
Journal:  Hematol Oncol       Date:  2004-09       Impact factor: 5.271

4.  The incidence and outcome of myeloid malignancies in 2,112 adult patients in southeast England.

Authors:  Karen J Phekoo; Mike A Richards; Henrik Møller; Steve A Schey
Journal:  Haematologica       Date:  2006-10       Impact factor: 9.941

5.  Population-based demographic study of karyotypes in 1709 patients with adult acute myeloid leukemia.

Authors:  R N Sanderson; P R E Johnson; A V Moorman; E Roman; E Willett; P R Taylor; S J Proctor; N Bown; S Ogston; D T Bowen
Journal:  Leukemia       Date:  2006-03       Impact factor: 11.528

6.  Trends in leukemia incidence and survival in the United States (1973-1998).

Authors:  Yang Xie; Stella M Davies; Ying Xiang; Leslie L Robison; Julie A Ross
Journal:  Cancer       Date:  2003-05-01       Impact factor: 6.860

Review 7.  The World Health Organization (WHO) classification of the myeloid neoplasms.

Authors:  James W Vardiman; Nancy Lee Harris; Richard D Brunning
Journal:  Blood       Date:  2002-10-01       Impact factor: 22.113

Review 8.  Molecular basis of the diagnosis and treatment of polycythemia vera and essential thrombocythemia.

Authors:  Andrew I Schafer
Journal:  Blood       Date:  2006-02-16       Impact factor: 22.113

9.  Epidemiology of myelodysplastic syndromes and chronic myeloproliferative disorders in the United States, 2001-2004, using data from the NAACCR and SEER programs.

Authors:  Dana E Rollison; Nadia Howlader; Martyn T Smith; Sara S Strom; William D Merritt; Lynn A Ries; Brenda K Edwards; Alan F List
Journal:  Blood       Date:  2008-04-28       Impact factor: 22.113

10.  Myelodysplastic syndromes: incidence and survival in the United States.

Authors:  Xiaomei Ma; Monique Does; Azra Raza; Susan T Mayne
Journal:  Cancer       Date:  2007-04-15       Impact factor: 6.860
View more
  7 in total

Review 1.  Chronic myelomonocytic leukemia prognostic classification and management: evidence base and current practice.

Authors:  Dorothée Selimoglu-Buet; Eric Solary
Journal:  Curr Hematol Malig Rep       Date:  2014-12       Impact factor: 3.952

2.  The EUTOS population-based registry: incidence and clinical characteristics of 2904 CML patients in 20 European Countries.

Authors:  V S Hoffmann; M Baccarani; J Hasford; D Lindoerfer; S Burgstaller; D Sertic; P Costeas; J Mayer; K Indrak; H Everaus; P Koskenvesa; J Guilhot; G Schubert-Fritschle; F Castagnetti; F Di Raimondo; S Lejniece; L Griskevicius; N Thielen; T Sacha; A Hellmann; A G Turkina; A Zaritskey; A Bogdanovic; Z Sninska; I Zupan; J-L Steegmann; B Simonsson; R E Clark; A Covelli; G Guidi; R Hehlmann
Journal:  Leukemia       Date:  2015-03-18       Impact factor: 11.528

3.  Natural history of chronic myelomonocytic leukemia treated with hypomethylating agents.

Authors:  Ana Alfonso; Guillermo Montalban-Bravo; Koichi Takahashi; Elias J Jabbour; Tapan Kadia; Farhad Ravandi; Jorge Cortes; Zeev Estrov; Gautam Borthakur; Naveen Pemmaraju; Marina Konopleva; Carlos Bueso-Ramos; Sherry Pierce; Hagop Kantarjian; Guillermo Garcia-Manero
Journal:  Am J Hematol       Date:  2017-05-26       Impact factor: 10.047

Review 4.  I walk the other line: myelodysplastic/myeloproliferative neoplasm overlap syndromes.

Authors:  Aaron T Gerds
Journal:  Curr Hematol Malig Rep       Date:  2014-12       Impact factor: 3.952

Review 5.  Polo-like kinases and acute leukemia.

Authors:  Oksana Goroshchuk; Iryna Kolosenko; Linda Vidarsdottir; Alireza Azimi; Caroline Palm-Apergi
Journal:  Oncogene       Date:  2018-08-13       Impact factor: 9.867

6.  Incidence of myeloid neoplasms in Spain (2002-2013): a population-based study of the Spanish network of cancer registries.

Authors:  Marta Solans; Arantza Sanvisens; Alberto Ameijide; Susana Merino; Dolores Rojas; Araceli Alemán; Emilia Banqueri; Matilde Chico; Ana Isabel Marcos; Visitación de Castro; Leire Gil; Arantza López de Munain; Montse Puigdemont; Maria-José Sánchez; Josefina Perucha; Patricia Ruiz-Armengol; Mª Dolores Chirlaque; Marcela Guevara; Marià Carulla; Rafael Marcos-Gragera
Journal:  Sci Rep       Date:  2022-01-10       Impact factor: 4.379

7.  Myeloid malignancies in the real-world: Occurrence, progression and survival in the UK's population-based Haematological Malignancy Research Network 2004-15.

Authors:  Eve Roman; Alex Smith; Simon Appleton; Simon Crouch; Richard Kelly; Sally Kinsey; Catherine Cargo; Russell Patmore
Journal:  Cancer Epidemiol       Date:  2016-04-16       Impact factor: 2.984
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.